Best Rectal cancer Doctors Worldwide — TOP 157

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Mustafa Solak specializes in gastrointestinal cancers, including rectal cancer, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Trained at Hacettepe University – one of Turkey's leading medical schools
• Completed fellowship at MD Anderson Cancer Center – a globally recognized oncology institution
• Specializes in gastrointestinal cancers alongside other oncology fields
• Works at Hisar Hospital Intercontinental – a prominent healthcare facility

Performed 400+ pancreatic and gastric cancer surgeries – Prof. Peker brings extensive expertise in complex gastrointestinal surgeries.

• Specialized in Hepatopancreatobiliary Surgery at Mayo Clinic
• Founded the HPB Surgery unit at Bakırköy Dr. Sadi Konuk Hospital
• Prof. at Başakşehir Çam and Sakura City Hospital
• PhD in Medical Biology with a focus on cancer

Dr. Vafi Atalay is a colorectal and general surgeon at Anadolu Medical Center. He developed the tube ileostomy technique to eliminate the need for ostomy-closure surgery. This method was published in the journal Colorectal Disease. Dr. Atalay specializes in pancreatic, colon, rectal, and liver cancers.

• Winner of the Gold Medal Award at the Istanbul International Invention Fair.
• Authored over 30 articles in national and international medical journals.
• Received the Best Scientific Research Award from several surgical congresses.
• Practices at a clinic affiliated with the top-ranked Johns Hopkins Hospital.

Assoc. Prof. Gorkem Turkkan has successfully completed over 2,500 radiotherapy sessions with the MR-Linac device – a leader in precision radiation treatment.

• Specializes in stereotactic radiotherapy and MRI-guided treatments
• Completed clinical research at Maastricht University's MAASTRO Clinic
• Member of both Turkish and European radiation oncology societies
• Published 27 articles and 31 conference presentations
• Currently involved in two TÜBİTAK research projects

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Over 12,000 laparoscopic surgeries performed – Dr. Ballesta Lopez pioneered minimally invasive techniques for rectal cancer at Centro Médico Teknon.

• 46 years of experience of clinical experience in digestive surgery
• Director of the Laparoscopic Center with Da Vinci robotic assistance
• IFSO-accredited Center of Excellence for surgical precision
• International trainer in advanced laparoscopic techniques

Dr. Sharon Peles leads the digestive tract tumors institute at Sourasky Medical Center, specializing in systemic treatments for rectal cancer.

• Director of the Institute of Tumors of the Digestive System
• Trained in gastrointestinal oncology at Royal Marsden Hospital in London
• Focuses on integrative approaches and innovative therapies
• Member of Israeli Association of Oncology and Radiology
• Lecturer at Tel Aviv University and author of scientific publications

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Prof. Zielinski leads Austria's largest oncology department and founded the Comprehensive Cancer Center Vienna, specializing in personalized rectal cancer treatments.

• Over 44 years of experience of experience in medical oncology and hematology
• Head of the Clinical Division of Oncology at Vienna General Hospital
• Pioneer in cancer immunotherapy and individualized therapies
• President of the Central European Cooperative Oncology Group

Professor Pfaffenbach performs over 9,000 endoscopic interventions annually as Head of the Center of Intestinal Oncology at Academic Hospital Solingen.

• 34 years of experience of clinical and operative practice in gastroenterology
• Specializes in treating malignant tumours of internal organs
• Author of 130+ publications in gastroenterology
• Member of European Society of Gastroenterology and Endoscopy

Professor Merimsky leads the bone and soft tissue tumor department at Sourasky Medical Center, specializing in tailored oncology treatments.

• Over 41 years of experience of experience in oncology
• Fellowship-trained in Paris for bone and soft tissue tumors
• Active member of ASCO and ESMO
• Published numerous scientific papers on oncology
• Chairs the Israeli Society for Clinical Oncology

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

3,500+ robotic surgeries performed – Dr. Tvaruzek heads the Center of Robotic Surgery at St. Zdislava Hospital.

• Leading certified expert by Intuitive Surgical (Da Vinci robots)
• Specializes in function-preserving prostatectomies and transoral tumor removal
• Member of Association of Aesthetic Medicine and Bariatric Surgery

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Specialized in gastrointestinal oncology for over 27 years of experience – Prof. Sağlam heads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University – one of Turkey's leading medical schools
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
• Previously worked at Istanbul University Oncology Institute

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.